CAI 9.52% 11.5¢ calidus resources limited

another bull announcement, page-2

  1. 56,509 Posts.
    lightbulb Created with Sketch. 257
    The market is a constant surprise package.
    An investor could have been forgiven for thinking that
    yesterday's announcement from PHARMANET (PNO) would attract some buying
    interest, particularly as the whole market was up.
    But PharmaNet fell 0.1c to 2.7c in minuscule trading.
    The day had started for the company with news that it received
    notice from its US subsidiary, Molecular Pharmacology, that
    "independent, replicated and multi-centred in-vitro studies had shown
    that the anti-cytokine drug, MPL-104, which it had licensed from
    PharmaNet's wholly owned subsidiary Cambridge Scientific, potently
    inhibits the secretion of TNF-alpha in inflammatory conditions.
    "The secretion of the cytokine TNF-alpha underlies a range of
    debilitating inflammatory diseases such as rheumatoid arthritis, lupus,
    Crohn's disease, psoriasis, and ankylosing spondylitis, and is
    considered to be the main factor in driving inflammation."
    Maybe this prose was too dense for traders but we suspect it
    said its anti-inflammatory drug appeared to be working.
    And as PharmaNet also pointed out, it's a big market - $4.6
    billion in 2005 and heading for more than $10 billion by 2015.

 
watchlist Created with Sketch. Add CAI (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
0.010(9.52%)
Mkt cap ! $93.67M
Open High Low Value Volume
10.5¢ 11.5¢ 10.5¢ $265.3K 2.456M

Buyers (Bids)

No. Vol. Price($)
1 11766 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 336976 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CAI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.